Pharmaids Pharmaceuticals Ltd

NSE: PHARMAID · BSE: 524572 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹29.17
Market cap: ₹102.9 Cr
Revenue (annual): ₹27.88 Cr
Net profit (annual): ₹-11.72 Cr
P/E (TTM): -24.6×Sector 43.8×
Promoter holding: 32.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

11 Nov 2026 19:23 IST BSE

Financial Results

Pharmaids Pharmaceuticals Q2 FY27 Results: Net Loss of ₹1.8 Cr, Loss Narrows

Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.3 Cr (-50.0% YoY) and a net loss of ₹1.8 Cr for Q2 FY27.

Key figure: Net loss ₹1.8 Cr

Open full results → Read the filing ↗

5 Nov 2026 17:45 IST BSE

Board Meeting Date

Pharmaids Pharmaceuticals Board Meeting Date

Pharmaids Pharmaceuticals Ltd intimated BSE of a board meeting on 11 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The notice contains no figures, and the trading window stays closed from 1 October 2026.

Open announcement → Read the filing ↗

13 Oct 2026 16:12 IST BSE

Other Announcement

Pharmaids Pharmaceuticals Other Announcement

Pharmaids Pharmaceuticals Limited filed its quarterly Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent confirming the dematerialization of shares.

Open announcement → Read the filing ↗